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Objectives: It is known that self-reported health
(SRH) declines with increasing age and that
comorbidity increases with age. We wished to examine
how age transfers its effect to SRH through comorbid
disease and mental illness and whether these
processes remained stable from 1994 until 2008.
The hypothesis is that ageing and/or the increased
age-related burden of pathology explains the declining
SRH.
Setting: The Tromsø Study (TS) is a cohort study
using a survey approach with repeated physical
examinations. It was conducted in the municipality of
Tromsø, Norway, from 1974 to 2008.
Participants: A total of 21 199 women and 19 229
men participated.
Primary and secondary outcome measures: SRH
is the outcome of interest. We calculated and
compared the effect sizes of age, comorbidity and
mental health symptoms using multimediator analysis
based on OLS regression.
Results: Ageing had a negative impact on SRH, but
the total effect of age decreased from 1994 to 2007.
We assessed the direct effect of age and then the
proportion of indirect age-related effects through
physical illness and mental health symptoms on the
total effect. The direct effect of age represented 79.3%
of the total effect in 1994 and decreased to 58.8% in
2007. Physical illness emerged as an increasingly
important factor and increased its influence from
15.7% to 41.2% of the total effect. Age alone had a
protective effect on mental health symptoms and this
increased (2.5% to 17.3%), but we found a stronger
association between mental health symptoms and
physical disease in the later waves of the study
(increasing from 3.7% to 14.8%).
Conclusions: The results suggest that the effect on
SRH of mental health symptoms caused by physical
illness is an increasing public health problem.
Treatment and care for specific medical conditions
must therefore focus more strongly on how these
conditions affect the patient’s mental health and
address these concerns accordingly.
INTRODUCTION
Self-reported health (SRH) is a subjective
assessment of current health status as seen by
the patient or participant. It is well known
that a whole range of biological, psycho-
logical and socioeconomic factors affect
SRH, and also that these factors interact.1–5
The research literature suggests that SRH is
produced in a cognitive process that is inher-
ently subjective and contextual, and also that
SRH predicts mortality and other health out-
comes; this shows that the basis of self-rated
health lies in the biological and physiological
state of the individual organism.6 Well-known
crucial biological factors that independently
affect SRH are specific medical conditions
(eg, cardiovascular diseases, diabetes and
asthma) and health risk factors (eg, resting
heart rate, blood pressure, cholesterol, BMI
and endocrine measures). Although the
effect of SRH attenuates when such variables
are controlled for, SRH still remains as an
independent variable for all-cause death and
other future health outcomes.7–11 Mental
health symptoms affect SRH, but mental
health is also affected by physical disease.
The literature suggests that severity of mental
health symptoms correlates with many spe-
cific medical conditions, and consequently
with impaired well-being. Comorbid strain
increases with increasing age, and older
Strengths and limitations of this study
▪ The sample comprises large, representative
samples of a general population with repeated
measures at ∼7-year intervals.
▪ Multimediator analysis allows for the interpret-
ation of the joint effect of age, comorbid disease
and mental health on self-reported health.
▪ We used the repeated measures as separate
cross-sectional data in the analysis.
▪ The first three panels (1974–1986) did not
include any adequate measurement of mental
health symptoms and were excluded, but the
CONOR-MHI (1994) was validated against the
Hopkins Symptom Checklist and showed good
agreement.
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people are particularly at risk of experiencing anxiety
and depression.12–17
To summarise, it is well documented that SRH
declines with increasing age but whether it is ageing
alone or the increased age-related burden of pathology
that explains this association is still unanswered. The
prevalence of coexisting chronic conditions is rising as
life expectancy increases in contemporary Western
society.18 The age-specific decline could mean that the
increasing level of pathology due to age explains this
specific decline of SRH and not ageing by itself.
There are, to the best of our knowledge, no studies
that describe the combined effect of ageing, comorbid
physical disease and mental health symptoms on general
perceived health status. Moreover, since medical treat-
ment has improved over the past three decades, leading
to increased life expectancy, it seems timely to ask
whether people’s experiences of ageing, comorbid
disease and mental health problems remain the same.
We wished to examine how age transfers its effect on
SRH through comorbid physical disease and mental
health symptoms. A further aim was to explore how
mental health symptoms are affected by physical disease




The Tromsø Study (TS) was a cohort study which pro-
vided data allowing us to estimate the impact of a broad
range of factors on a general population, using surveys
and physical examinations in a large representative
sample.19 TS consisted of six surveys conducted in
Tromsø in Northern Norway from 1974 to 2008. We
used consecutive cross-sectional analyses within the TS.
The study population was recruited from all inhabitants
in specific age groups. The aim was to include large, rep-
resentative samples of the Tromsø population, with the
invitation of whole birth cohorts and random samples.
The attendance rate was high (66–75%). A total of
21 199 women and 19 229 men gave informed signed
consent and attended up to 6 separate health examina-
tions. Tromsø 1 was a heart study conducted in 1974
and included only men aged 20–49. Tromsø 2
followed-up the first study in 1979–1980 but included
men (aged 20–54) and women (aged 20–49). Tromsø 3
was executed in 1986–1987 and included men and
women in the 20–56 age range, and a 10% random
selection of persons aged 12–19. We excluded Tromsø
1–3. SRH was introduced during the 1980s; Tromsø 1
and 2 thus lack SRH and Tromsø 3 did not include any
adequate measurement of mental health symptoms. Our
sample starts with Tromsø 4 in 1994. Tromsø 4 is the
largest wave, and participants were followed-up in 2001
and 2007/2008. We excluded those with missing data
(n=736 in TS4, n=1132 in TS5 and n=767 in TS6). The
final analysis therefore comprised 12 408 men and
13 579 women from TS4, 3108 men and 3746 women
from TS5 and 5769 men and 6338 women from TS6.
The Norwegian Data Protection Authority and the
Regional Committees for Medical and Health Research
Ethics North Norway approved the TS.
Measurements
The participants completed a self-administrated ques-
tionnaire with questions on a broad range of diseases
and symptoms, health behaviour, social conditions, edu-
cation, financial situation and level of physical activity.
Self-reported health (SRH): The independent variable SRH
was reported by answering the question, ‘What is your
current state of health?’ with answers ranging from very
bad (0) to very good (4) in Tromsø 6, and from poor
(1) to very good (4) in Tromsø 4 and 5. Specific medical
conditions: We selected 13 symptomatic medical condi-
tions reported in all panels. These were psoriasis, food
allergies, chronic bronchitis, migraine, ulcer, asthma,
thyroid disease, arthritis, myocardial infarction, cerebro-
vascular stroke, diabetes, osteoporosis and angina. The
conditions were self-reported by answering questions
such as ‘Do you have or have you had….?’ We used the
Health Impact Index (HII) to measure the comorbid
conditions. Diseases have a varied impact on SRH. HII
classifies patients with comorbid disease according to
the impact that each condition has on SRH by assigning
a weight for each condition. HII equals the total score of
each condition of the participant. HII thus considers the
severity and joint effects of the conditions.4 The range
was 0–18 in TS4, 0–17 in TS5 and 0–22 in TS 6. Online
supplementary appendix 1 shows the conditions
included with their weights and prevalence in the differ-
ent waves.
Mental health symptoms were based on a well-
validated self-report symptom inventory comprising
questions representative of the symptom configurations
of anxiety and depression commonly observed among
outpatients. It includes questions such as ‘Have you
experienced sudden fear without apparent reason’, ‘…
felt tense or upset’, ‘…easily blamed yourself’, ‘…felt
depressed or sad’, ‘…felt useless or worthless’, ‘…felt
that everything is a struggle’ or ‘…felt hopelessness’.
Each answer is scored from 1 to 4. The measurement is
the average score. The range was therefore 1–4 in all
waves. The mental health index (CONOR-MHI) used at
T4 has been compared with the Hopkins Symptom
Checklist (HSCL) with reasonably good agreement. In
the following surveys T5–6, the HSCL was used. A cut-off
level of 2.15 for significant symptoms is equivalent to the
1.85 level in HSCL-10.20 21
Analysis
The purpose of the descriptive statistics was to define
the distribution of SRH, comorbid disease and mental
health across samples, age groups and gender. We used
cross tabulation and two-way ANOVA to describe the
characteristics of the sample. Multimediator analysis was
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used for the analysis of the conditional nature of the
mechanism by which age transmits its effect on SRH.
The advantage of this method is that it allows for the
interpretation of multiple confounders that may func-
tion as either mediators or moderators and interprets
their joint effect on the statistical model derived from
the theoretical model.22 23 The analytical goal of the
multimediation analysis was to determine how age trans-
fers its effect to SRH directly and through physical
disease and mental illness. The first step was the concep-
tual model, which we based on the idea that age repre-
sents the timeline of life in which events like disease
occur and physical condition changes. Previous analysis,
tracking individual subjects, confirms that SRH
decreases with increasing age and whenever levels of
pathology increase. This implies that age might influ-
ence SRH either directly or indirectly through pathology
as life events. The second step was to translate the con-
ceptual model into a statistical model. Figure 1 shows
the conceptual model and its translation into a statistical
model.24 The statistical model includes SRH as the
outcome (Y), age as the main variable (X) with medical
condition (M1) and mental health symptoms (M2) as
mediators. Our statistical model includes three indirect
effect lines (Ind 1–3).
▸ Ind 1: Age→HII→SRH (a1×b1)
▸ Ind 2: Age→HII→HSCL→SRH (a1×d21×b2)
▸ Ind 3: Age→HSCL→SRH (a2×b2)
We used multiple regression to assess the two media-
tors (M1=medical conditions and M2=mental health)
and the reaction (Y=SRH). The regression coefficients,
95% CIs and model summary information for the
mediated effect of age on SRH have been published as
online supplementary appendix 2.
RESULTS
Characteristics and total effect of age
Table 1 shows the characteristics of the four samples
indicating increasing comorbidity with a shift in 2001
(T5) when the comorbid levels decreased with a corre-
sponding increase in SRH. Figure 2 shows profile plots
for SRH, comorbidity and ratio of persons with subthres-
hold and significant mental health symptoms across age
and gender. Testing for gender and age differences with
two-way ANOVA showed that all mean differences were
significant (p<0.0001) for SRH. Here, SRH declined sig-
nificantly with increasing age with a corresponding
increase in comorbidity at all three survey points.
Although the gender differences were statistically signifi-
cant for all three factors, the gender difference in SRH
was less than a 10-year age difference in SRH in all
waves. For comorbidity, the gender difference was as
large as a 10-year age difference for the two intermedi-
ate survey points, but less so at the first and last survey
points where the gender difference was small. For
comorbidity, the most striking finding was the increase
by age across all surveys, especially for women, who had
an increasing burden of disease as they got older. For
mental health symptoms, the greater burden for women
was most striking.
The total effect of age
We used an OLS regression model to determine the
total effect of age on SRH. Table 2 shows the linear
model of the total effect of age on SRH. We see that age
had a negative effect on SRH in all samples, and also
that the total effect of age attenuated from 1994 to 2008
in parallel with increasing life expectancy in the region.
In our model, each year of age represented −0.0175 (CI
−0.018 to −0.017) deterioration of SRH in T4 but the
effect dropped to −0.013 (CI −0.014 to −0.012) in T6.
The indirect effect of pathology
The M1 models in online supplementary appendix 2
show that higher comorbidity was associated with
increasing age in all waves (Coeff=0.050 in T4; 0.059 in
T5; 0.050 in T6). The M2 models show a significant
effect for age on mental health symptoms (Coeff=
−0.0002 in T4; −0.0025 in T5; −0.0029 in T6), although
Table 1 Distribution of SRH, physical condition and
demographics, specific medical conditions, mental health
symptoms and social context by gender in Tromsø 4–6
(1994–2008)
Tromsø 4 Tromsø 5 Tromsø 6
Self-rated health
(mean/SD)
2.82 (0.70) 2.7 (0.67) 2.74 (0.77)
Age (mean/SD) 48.1 (14.8) 60.1 (13.8) 58.7 (12.4)
Health impact index
(mean/SD)
0.95 (1.66) 1.72 (2.18) 1.66 (2.21)
Mental health
symptoms (mean/SD)
1.25 (0.36) 1.29 (0.38) 1.52 (0.41)
SRH, self-reported health.
Figure 1 Conceptual and statistical diagram for the
mediated effect of age on SRH through comorbid disease and
mental health symptoms.
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medical conditions when they occurred affected mental
health symptoms more than age (0.030 in T4; 0.032 in
T5; 0.041 in T6). All effect lines in the statistical model
were estimated by a series of OLS regression models
(see online supplementary appendix 2). Table 3 shows
the indirect and direct effects of age on SHR. We calcu-
lated these from the coefficients in online
supplementary appendix 2 according to our statistical
model. Adding gender as a moderator on each effect
line did not change the overall results.
We found that age had a direct and indirect effect on
SRH. The direct effect (c′) of age attenuated from 1994
to 2008 (T4: c′=−0.013, T5: c′=−0.011, T6: c′=−0.008).
This suggests that age affected SRH independently of
pathology even when controlling for the mediators, and
also that age itself had a lower impact on SRH at the
latest measuring point.
We found that age had an increasing negative indirect
effect through comorbid diseases (T4: −0.0034; T5:
−0.0035; T6: −0.0042). Since the total effect attenuated
in the same period, this implied that the ratio of total to
indirect effect of comorbid disease increased
correspondingly more. It was 0.192 in 1994, 0.236 in
2001 and 0.330 in 2007/2008. This trend implied that
physical disease was an increasingly important factor
relative to age itself to explain why SRH declines with
increasing age.
The second indirect effect (Age→HII→HSCL→SRH)
included mental health symptoms associated with having
a disease. We found a negative effect on SRH T4 of
−0.0006, T5 of −0.0013 and T6 of −0.0019. This suggests
that having a physical disease was associated with higher
levels of mental health symptoms, which in turn affected
SRH. The ratio of total to indirect effect of comorbid
disease was −0.037 in T4, −0.086 in T5 and −0.148 in
T6. Thus, we see a consistent increase in the relative size
of the second indirect effect from 1994 to 2007/2008.
This implied that the relative significance of mental
health issues connected to physical disease increased
during this period and at 14.8% of the total effect, it is
also clinically significant.
The third indirect effect line (Age→HSCL→SRH)
revealed that SRH increased with increasing age, which
implies that mental health symptoms are associated with
Figure 2 Profile plots for self-reported health for interaction effects between age and gender with 95% CIs. Self-reported health:
Range from very poor (0) to very good (4) in TS 6, and poor (1) to very good (4) in TS 4 and 5. Comorbid disease: Number of
diseases grouped into a score with range 0–17 (mean 0.97) in TS 4, range 0–17 (mean 1.59) in TS 5 and range 0–19 (mean
1.53) TS 6. Mental health symptoms: CONOR-MHI with range 1–4 (mean 1.52) in TS 4, and HSCL-10 with range 1–4 in TS 5
and 6 (mean 1.25 in TS 5 and mean 1.29 in TS 6). All differences p<0.001. Red lines=women, blue lines=men, CI 95% is
SE*1.96.
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increasing age when controlled for physical disease. The
ratio of effect size increased during this period from
0.002 in T4 to −0.0109 in T5 and −0.200 in T6. This
implied that when we disregard physical illness and
mental health problems associated with physical illness,
increasing age had a beneficial effect on SRH.
DISCUSSION
Ageing affected SRH directly and also indirectly
through increased levels of pathology. We observed a
change in how ageing and physical disease influenced
SRH between the different waves. The direct effect of
ageing (c′) represented 79.3% of the total effect in
1994, 69.8% in 2001 and 58.8% in 2007/2008. This
means that ageing is still the most important factor for
SRH, but that ageing itself became relatively less
important between the waves. Meanwhile, physical
disease became an increasingly important factor for
SRH. As shown in table 3, comorbid conditions (HII)
represented 15.7% of the total effect in 1994, 26.7% in
2001 and 41.2% in the last wave in 2007/2008.
Furthermore, ageing itself had a protective effect on
mental health symptoms which increased (2.0–20.0%
of the total effect). We found a stronger association
between mental health symptoms and physical disease
in the later waves (increasing from 3.7% to 14.8%).
Mental health symptoms related to physical disease
consequently led to lower SRH levels in the later parts
of the study.
Physical disease is known to be related to mental
health symptoms of anxiety and depression, which the
HSCL-10 scale is especially sensitive to measure in a
general population.15 Epidemiological data suggest that
severity of mental health symptoms correlates with
disease, for example, one-third of stroke survivors
develop depression12 and one-quarter anxiety disor-
ders.13 Cardiovascular diseases have shown discrete
effects for panic disorder and specific phobia.14 15 Older
people with illnesses such as coronary heart disease,
arthritis and chronic lung disease show increased levels
of depressed mood and impaired well-being.16
Cumulative stress exposure across different stress
domains contributes to depressive symptoms in cancer
survivors.17 Moreover, pessimism, negative cancer-related
rumination and physical symptom distress predicted
anxiety and depression trajectories.
However, our findings indicate that physical disease in
recent decades has become more strongly associated
with mental health symptoms, that is, the indirect effect
on mental health symptoms via physical disease has
increased over time. Accordingly, it seems plausible that
physical diseases in terms of SRH affect us more than
before, and also that physical disease has a greater
impact on our reaction towards illness than before. So
how can we explain these findings? Why does physical
disease trigger symptoms of anxiety and depression
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One possible explanation may be found in social
changes in Norway and the Norwegian healthcare
system. Although we today have curative and palliative
treatment of many more physical disorders, and more
individuals have access to treatment, there is also an
increased expectation of ‘active ageing’ and healthy
living.25 26 This expectation is realistic, as the incidence
of especially cardiovascular diseases has been rapidly
declining for several decades, but is contrasted by a
decreasing case fatality, leaving more of those who still
get cancer, coronary heart attacks and stroke with lasting
disability as more people survive.27
SRH can reflect the states of the human body and
mind. People base their health assessments on different
types of information and contextual frameworks.6 It is
plausible that people who expect to age actively become
unhappy or worried when encountering limitations and
disease. It may also be argued that people tend to
respond negatively to questions on their health or limita-
tions when comparing their situation with others at
similar age. Bodily sensations that are directly available
to the individual are another source of information.6
Accordingly, it seems plausible that people compare
current body status with the situation before the disease
occurred, and experience fear of relapse or having
another disease. We cannot answer this assumption
based on three cross-sectional analyses; however, it is a
hypothesis that could be answered by tracking indivi-
duals in the TS cohort.
Furthermore, current healthcare services are organised
to place greater emphasis on efficiency than on care, and
society has a faster pace of life so that older people more
often live alone and isolated than a few decades ago.
From an evolutionary perspective, symptoms of anxiety
and depression are understood as normal reactions to
life-threatening and uncontrollable situations. For
example, fear is an obvious adaptive function as it
stimulates the ‘fight-or-flight’ response when the individ-
ual is exposed to a threat or dangerous situation; unless
the individual can escape, it will hide or ‘freeze’ the situ-
ation.28 Furthermore, Gilbert describes anxiety disorders
as a maladaptive expression or phenotype of the original
functional fear system where the acute stress response is
triggered in an inappropriate manner.29 Similarly, Nettle
proposes that depression may represent a maladaptive
expression of an original functional control system for
positive affect, that is, a functional downregulation of
positive affect in certain situations and contexts.30 Gilbert
describes such a downregulation of positive affect as a
defensive reaction, a similar fight-or-flight response, in
situations where the individual experiences loss of
control over aversive events or over significant resources
including the social environment.29 An increased inci-
dence of comorbid physical disorders with consequent
reduced access to social participation can thus be a plaus-
ible explanation of an increase in mental symptoms
related to physical disorders.
Interestingly, we found that age by itself was protective
of mental health symptoms when controlled for the
mental health symptoms associated with physical illness.
Several studies focus on how physical disease is associated
with increased risk of mental health symptoms. In our
study, this mechanism represented 5% of the total effect
in 1994, 6% in 2001 and 12% in 2008. Our findings
concur with studies on patient populations showing that
mental health is an important aspect of impairment of
SRH when physical illness occurs.
Strengths and limitations of the method
HII includes 13 symptomatic medical conditions, but
does not include risk factors such as hypertension and
dyslipidemia. These could be included as mediators on
the age->HII->SRH effect line, but this did not change
the overall findings of the model. The TS includes
Table 3 Direct and indirect effect size with 95% bias corrected CIs in parentheses, SEs and ratio of indirect to direct effect of
age on self-reported health
Tromsø 4 Tromsø 5 Tromsø 6
Effect (95% CI) Effect (95% CI) Effect (95% CI)
Total effect of age on SRH −0.0175 (−0.0181 to −0.0170) −0.0146 (−0.0157 to −0.0136) −0.0128 (−0.0139 to −0.0117)
Indirect effect of age on SRH
Total −0.0034 (−0.0032 to −0.0037) −0.0039 (−0.0034 to −0.0043) −0.0046 (−0.0040 to −0.0052)
Age→HII→SRH −0.0027 (−0.0028 to −0.0027) −0.0043 (−0.0044 to −0.0041) −0.0053 (−0.0054 to −0.0051)
Age→HII→HSCL→SRH −0.0006 (−0.0006 to −0.0007) −0.0013 (−0.0011 to −0.0014) −0.0019 (−0.0017 to −0.0021)
Age→HSCL→SRH 0.000* (0.0002 to −0.0002) 0.0016 (0.0021 to 0.0011) 0.0026 (0.0032 to 0.0020)
Ratio of indirect to total effect of age on SRH
Total 0.195 (0.176 to 0.215) 0.267 (0.217 to 0.318) 0.360 (0.284 to 0.442)
Age→HII→SRH 0.157 (0.154 to 0.158) 0.290 (0.281 to 0.299) 0.412 (0.391 to 0.433)
Age→HII→HSCL→SRH 0.037 (0.031 to 0.043) 0.086 (0.071 to 0.102) 0.148 (0.122 to 0.179)
Age→HSCL→SRH 0.002* (−0.010 to 0.013) −0.109 (−0.135 to −0.083) −0.200 (−0.229 to −0.170)
CIs and SEs are based on 1000 bootstrap samples.
Indirect effect of X on Y through Mi only=ai×bi, indirect effect of X on Y through M1 and M2 in serial=a1× d21×b2, direct effect of X on Y=c′.
The ratio of indirect effect to direct effect=Mi/c′(figure 1, statistical diagram).
*CIs include zero.
HII, Health Impact Index; HSCL, Hopkins Symptom Checklist; SRH, self-reported health.
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cancer but it is self-reported and does not distinguish
between those with an active illness and those who have
had cancer. That was the most likely explanation for why
it did not add to the model4 and was therefore not
included.
Although measured on an ordinal scale, the underlying
phenomenon of SRH is continuous, and the scales repre-
sent similar logical increments. Furthermore, the distri-
bution of SRH, apart from being staggered, resembled
the shape of a normal distribution. Hence, an OLS
regression model could be used for the analysis of inde-
pendent associations in the multivariable model.22
Adding gender as a moderator on each effect line did
not change the overall results. Mental health symptoms
were measured with different instruments, which may
have affected our findings. T5 and T6 used the Hopkins
Symptom Checklist (HSCL-10), which is a self-reported
symptom inventory comprising 10 items representative of
the symptom configurations of anxiety and depression
commonly observed among outpatients.20 T4 used the
CONOR Mental Health Index (MHI). This was based on
seven questions concerning different symptom configura-
tions of anxiety and depression. It was partly derived
from HSCL-10 and the General Health Questionnaire
(GHQ). Fortunately, Tromsø 4 is included in the
CONOR database that also included HSCL-10. The index
has therefore been compared with HSCL-10 with reason-
ably good agreement. It has been concluded that the
scales can be used in epidemiological studies. For com-
parisons, it is recommended to use the cut-off level of
2.15 for significant symptoms as equivalent to the 1.85
level in HSCL-10.21 31
CONCLUSIONS
As medicine advances and life expectancy increases, we
have higher expectations for the healthcare system and
to remain healthy even in old age. The results suggest
that the effect on SRH of mental health symptoms
caused by physical illness is an increasing public health
problem. It seems that our resilience to diseases is
decreasing. Therefore, treatment and care for specific
medical conditions must focus more strongly on how
these conditions affect the patient’s mental health and
address these concerns accordingly.
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